Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer

ANZ Journal of Surgery

Volumn 77, Issue 11, 2007, Pages 941-947

  Lim, Elgene ^a   Thomson, Benjamin N J ^a   Heinze, Stefan ^a   Chao, Michael ^a   Gunawardana, Dishan ^a   Gibbs, Peter ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Colorectal cancer; Liver metastasis; Management; Resection

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE SEVERITY; HUMAN; LIVER METASTASIS; PATIENT ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE CARE; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 35248898238     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2007.04287.x     Document Type: Review

References (71)

1. Australian Institute of Health and Welfare (AIHW) 2007. ACIM (Australian Cancer Incidence and Mortality) Books. AIHW : Canberra.
2. Millikan KW, Staren ED, Doolas A. Invasive therapy of metastatic colorectal cancer to the liver. Surg. Clin. North Am. 1997 77 : 27 8.
3. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg. 2002 235 : 759 66.
4. Ruers TJ, Langenhoff BS, Neeleman N et al. Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J. Clin. Oncol. 2002 20 : 388 95.
5. Bipat S, van Leeuwen MS, Comans EF et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 2005 237 : 123 31.
6. Jarnagin WR, Fong Y, Ky A et al. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J. Am. Coll. Surg. 1999 188 : 33 42.
7. Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 2005 104 : 2658 70.
8. Fong Y, Saldinger PF, Akhurst T et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am. J. Surg. 1999 178 : 282 7.
9. Topal B, Flamen P, Aerts R et al. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur. J. Surg. Oncol. 2001 7 : 175 9.
10. Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot FR. Prospective evaluation of the impact of (18F)fluro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br. J. Surg. 2005 92 : 362 9.
11. Flamen P, Stroobants S, Van Cutsem E et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D- glucose in recurrent colorectal cancer. J. Clin. Oncol. 1999 17 : 894 901.
12. Akhurst T, Kates TJ, Mazumdar M et al. Recent chemotherapy reduces the sensitivity of [18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J. Clin. Oncol. 2005 23 : 8713 16.
13. Cohade C, Osman M, Leal J et al. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J. Nucl. Med. 2003 44 : 1797 803.
14. Jarnagin WR, Conlon K, Bodniewicz J et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 2001 15 : 1121 8.
15. Grobmyer SR, Fong Y, D'Angelica M, Dematteo RP, Blumgart LH, Jarnagin WR. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch. Surg. 2004 139 : 1326 30.
16. Ekberg H, Tranberg KG, Andersson R et al. Determinants of survival in liver resection for colorectal secondaries. Br. J. Surg. 1986 73 : 727 31.
17. Registry of hepatic metastases. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of indicators for resection. Surgery 1988 103 : 278 88.
18. Adam R, Pascal G, Castaing D et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann. Surg. 2004 240 : 1052 61 discussion 1061-4.
19. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann. Oncol. 2001 12 : 887 94.
20. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 1999 230 : 309 18 discussion 318-21.
21. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J. Clin. 1995 45 : 50 62.
22. Poston GJ, Adam R, Alberts S et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J. Clin. Oncol. 2005 23 : 7125 34.
23. Goldberg RM. Advances in the treatment of metastatic colorectal cancer. Oncologist 2005 10 (Suppl. 3 40 48.
24. Giacchetti S, Perpoint B, Zidani R et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J. Clin. Oncol. 2000 18 : 136 47.
25. Hurwitz H, Fehrenbacher L, Novotony W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 2004 350 : 2335 42.
26. Tabernero JM, Van Cutsem E, Sastre J et al. An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results. Proc Am Soc Clin Oncol 2004 : 22 : 14S : 3512.
27. Vauthey JN, Pawlik TM, Ribero D et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 2006 24 : 2065 72.
28. Adam R, Avisar E, Ariche A et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal cancer. Ann. Surg. Oncol. 2001 8 : 347 53.
29. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J. Clin. Oncol. 2005 23 : 2038 48.
30. Kelly RJ, Kemeny NE, Leonard GD. Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin. Colorectal Cancer 2005 5 : 166 74.
31. Vauthey JN, Marsh Rde W, Cendan JC, Chu NM, Copeland EM. Arterial therapy of hepatic colorectal metastases. Br. J. Surg. 1996 83 : 447 55.
32. Gray BN, Anderson JE, Burton MA et al. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust. N. Z. J. Surg. 1992 62 : 105 10.
33. Gray BN, Van Hazel G, Hope M et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastase from primary large bowel cancer. Ann. Oncol. 2001 12 : 1711 20.
34. Lau WY, Ho SKW, Yu SCH, Lai CM, Leung TWT. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann. Surg. 2004 240 : 299 305.
35. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J. Clin. Oncol. 2005 23 : 1 11.
36. Conlon R, Jacobs M, Dasgupta D, Lodge JP. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur. J. Ultrasound 2003 16 : 211 16.
37. Carmignani CP, Ortega-Perez G, Sugarbaker PH. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur. J. Surg. Oncol. 2004 30 : 391 8.
38. Elias DM, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur. J. Surg. Oncol. 2006 32 : 632 6.
39. Laurent C, Sa Cunha A, Rullier E, Smith D, Rullier A, Saric J. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J. Am. Coll. Surg. 2004 198 : 884 91.
40. Elias DM, Ouellet JF. Incidence, distribution, and significance of hilar lymph node metastases in hepatic colorectal metastases. Surg. Oncol. Clin. N. Am. 2003 12 : 221 9.
41. Shoup M, Gonen M, D'Angelica M et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J. Gastrointest. Surg. 2003 7 : 325 30.
42. Melendez J, Ferri E, Zwillman M et al. Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J. Am. Coll. Surg. 2001 192 : 47 53.
43. Martin R, Paty P, Fong Y et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal metastasis. J. Am. Coll. Surg. 2003 197 : 233 41 discussion 241-2.
44. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann. Surg. 2000 232 : 777 85.
45. Bismuth H, Adam R, Levi F et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann. Surg. 1996 224 : 509 22 discussion 520-22.
46. Adam R, Bismuth H, Castaing D et al. Repeat hepatectomy for colorectal liver metastases. Ann. Surg. 1997 225 : 52 62 discussion 60-62.
47. Wang WD, Liang LJ, Huang XQ, Yin XY. Low central venous pressure reduces blood loss in hepatectomy. World J. Gastroenterol. 2006 12 : 935 9.
48. DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J. Gastrointest. Surg. 2000 4 : 178 84.
49. Zorzi D, Mullen JT, Abdalla EK et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J. Gastrointest. Surg. 2006 10 : 86 94.
50. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur. J. Surg. Oncol. 2006 32 : 557 63.
51. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transaction of the liver be performed? a prospective randomized study in 100 consecutive patients: comparing four different transaction strategies. Ann. Surg. 2005 242 : 814 22 discussion 822-3.
52. Benoist S, Brouquet A, Penna C et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J. Clin. Oncol. 2006 24 : 3939 45.
53. Hemming AW, Reed AI, Howard RJ et al. Preoperative portal vein embolization for extended hepatectomy. Ann. Surg. 2003 237 : 686 91 discussion 691-3.
54. Selzner N, Pestalozzi BC, Kadry Z, Selzner M, Wildermuth S, Clavien PA. Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy. Br. J. Surg. 2006 93 : 587 92.
55. Lodge JP, Ammori BJ, Prasad KR, Bellamy MC. Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal liver metastases. Ann. Surg. 2000 231 : 471 9.
56. Kappel S, Kandioler D, Steininger R et al. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer. Transplantation 2006 81 : 64 70.
57. Rena O, Casadio C, Viano F et al. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. Eur. J. Cardiothorac. Surg. 2002 21 : 906 12.
58. Ike H, Shimada H, Togo S, Yamaguchi S, Ichikawa Y, Tanaka K. Sequential resection of lung metastasis following partial hepatectomy for colorectal cancer. Br. J. Surg. 2002 89 : 1164 8.
59. Saito Y, Omiya H, Kohno K et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J. Thorac. Cardiovasc. Surg. 2002 124 : 1007 13.
60. Kemeny N, Huang Y, Cohen AM et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 1999 341 : 2039 48.
61. Kemeny MM, Adak S, Gray B et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J. Clin. Oncol. 2002 20 : 1499 505.
62. Portier G, Rougier P, Milan C et al. Adjuvant systemic chemotherapy (CT) using 5-fluorouracil (FU) and folinic acid (FA) after resection of liver metastases (LM) from colorectal (CRC) origin. Results of an intergroup phase III study (trial FFCD - ACHBTH - AURC 9002). Proc Am Soc Clin Oncol 2002 : 21 : 528.
63. Langer B, Bleiberg H, Labianca R et al. Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Clin Oncol 2002 : 21 : 592.
64. Elias D, Debaere T, Muttillo I, Cavalcanti A, Coyle C, Roche A. Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J. Surg. Oncol. 1998 67 : 190 91.
65. Solbiati L, Livraghi T, Goldberg SN et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001 221 : 159 66.
66. McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am. J. Roentgenol. 2001 176 : 3 16.
67. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br. J. Surg. 2003 90 : 1240 43.
68. Aloia TA, Vauthey JN, Loyer EM et al. Solitary colorectal liver metastasis: resection determines outcome. Arch. Surg. 2006 141 : 466 7.
69. Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ. Radiofrequency ablation of liver tumours: a systematic review. Arch. Surg. 2006 141 : 181 90.
70. Robertson JM, Lawrence TS, Walker S, Kessler ML, Andrews JC, Ensminger WD. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995 32 : 445 50.
71. Herfarth KK, Debus J, Lohr F et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J. Clin. Oncol. 2001 19 : 164 70.